AAAAAA
Results:
1-7
|
Results: 7
Authors:
Maton, PN
Vakil, NB
Levine, JG
Hwang, C
Skammer, W
Lundborg, P
Citation: Pn. Maton et al., Safety and efficacy of long term esomeprazole therapy in patients with healed erosive oesophagitis, DRUG SAFETY, 24(8), 2001, pp. 625-635
Authors:
Maton, PN
Citation: Pn. Maton, Zollinger-Ellison syndrome and other acid-hypersecretory states, CLIN GAS, 2001, pp. 89-101
Authors:
Sarosiek, J
Jensen, RT
Maton, PN
Peura, DA
Harlow, D
Feng, TQ
McCallum, RW
Pisegna, JR
Citation: J. Sarosiek et al., Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison Syndrome: Its protective potential, AM J GASTRO, 95(5), 2000, pp. 1158-1165
Authors:
Metz, DC
Pratha, V
Martin, P
Paul, J
Maton, PN
Lew, E
Pisegna, JR
Citation: Dc. Metz et al., Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease, AM J GASTRO, 95(3), 2000, pp. 626-633
Authors:
Maton, PN
Orlando, R
Joelsson, B
Citation: Pn. Maton et al., Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease - a prospective, controlled trial, ALIM PHARM, 13(6), 1999, pp. 819-826
Authors:
Maton, PN
Burton, ME
Citation: Pn. Maton et Me. Burton, Antacids revisited - A review of their clinical pharmacology and recommended therapeutic use, DRUGS, 57(6), 1999, pp. 855-870
Authors:
Revicki, DA
Sorensen, S
Maton, PN
Orlando, RC
Citation: Da. Revicki et al., Health-related quality of life outcomes of omeprazole versus ranitidine inpoorly responsive symptomatic gastroesophageal reflux disease, DIGEST DIS, 16(5), 1998, pp. 284-291
Risultati:
1-7
|